Fluorescence properties of Laurdan in cochleate phases

2003/11/11 by Karthik Ramani, Sathyamangalam V Balasubramanian, Sathyamangalam V. Balasubramanian · 12 citations
Biochemistry, Genetics and Molecular Biology · Chemistry · #Lipid Membrane Structure and Behavior #Surfactants and Colloidal Systems #RNA Interference and Gene Delivery

paper · doi:10.1016/j.bbamem.2003.10.009

Citations

• Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence
• Cholesterol modifies water concentration and dynamics in phospholipid bilayers: a fluorescence study using Laurdan probe
• Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence

Cited by

• The evolution of steady-state laurdan fluorescence: From model membranes to cellular applications
• Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicity. [europepmc]
• O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII. [europepmc]
• Development and characterization of lipidic cochleate containing recombinant factor VIII. [europepmc]
• Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIII. [europepmc]
• Immunogenicity and pharmacokinetic studies of recombinant factor VIII containing lipid cochleates. [europepmc]
• Lipid complexes with cationic peptides and OAKs; their role in antimicrobial action and in the delivery of antimicrobial agents. [europepmc]
• Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes. [europepmc]
• Investigation of the Lipid Binding Properties of the Marburg Virus Matrix Protein VP40. [europepmc]
• Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model. [europepmc]
• Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents. [europepmc]
• Feasibility of the preparation of cochleate suspensions from naturally derived phosphatidylserines. [europepmc]